Breaking News Instant updates and real-time market news.

TNDM

TNDM

16:32
04/23/18
04/23
16:32
04/23/18
16:32

Tandem Diabetes announces insulin pump distribution deals in Australia and NZ

Tandem Diabetes Care announced that it has entered into distribution agreements with Australasian Medical & Scientific Ltd and New Zealand Medical & Scientific Ltd to commercialize Tandem's t:slim X2 Insulin Pump in Australia and New Zealand, respectively. Under the terms of the arrangements, the diabetes divisions of AMSL and NZMS will perform all sales, marketing, and customer training and support for Tandem's products in the regions. Timing for availability of Tandem products in Australia and New Zealand has not yet been announced.

  • 26

    Apr

  • 08

    May

TNDM TNDM

03/28/18
COWN
03/28/18
UPGRADE
Target $7
COWN
Outperform
Tandem Diabetes upgraded to Outperform from Market Perform at Cowen
Cowen analyst Doug Schenkel upgraded Tandem Diabetes to Outperform and raised his price target for the shares to $7 from $5.
03/28/18
COWN
03/28/18
UPGRADE
Target $7
COWN
Outperform
Tandem Diabetes upgraded to Outperform on market share gains at Cowen
As reported previously, Cowen analyst Doug Schenkel upgraded Tandem Diabetes (TNDM) to Outperform from Market Perform. The analyst cited his recent diabetes devices survey, which suggested the company is picking up market share from Animas' market exit and he sees excitement about its integration with Dexcom (DXCM). Schenkel raised his price target to $7 from $5 on Tandem Diabetes shares.
04/10/18
PIPR
04/10/18
NO CHANGE
PIPR
Neutral
Too early to call Tandem Diabetes revenue beat a trend, says Piper Jaffray
Piper Jaffray analyst JP McKim noted that Tandem Diabetes announced preliminary Q1 revenue that beat his estimate of $24.8M and the consensus view near $25M. McKim, who thinks the company "clearly benefited" from the exit of Animas from the U.S. market, is incrementally more positive on Tandem but awaits more evidence of an accelerating growth trend before changing his Neutral rating on the stock.
04/17/18
PIPR
04/17/18
NO CHANGE
PIPR
J&J commentary positive for pure-play spine names, says Piper Jaffray
Piper Jaffray analyst Matt O'Brien is out discussing derivative calls following Johnson & Johnson's (JNJ) Q1 results. The orthopedic market looked relatively stable, though Hips were notably softer than expected, O'Brien tells investors in a research note. He believes Stryker (SYK) is "clearly taking market share," which he views as an incremental negative for Zimmer Biomet (ZBH). On Spine, some U.S. weakness was expected, but J&J's results could be viewed as concerning given continued weakness since Q3 of 2017, the analyst adds. He thinks the end markets "are ok" and the commentary on J&J losing share benefits pure-play spine names NuVasive (NUVA), Globus Medical (GMED), SeaSpine (SPNE) and K2M Group (KTWO). He believes the pure-plays continue to out-innovate and take share despite the weakness in the overall category. Johnson & Johnson's results also show that the U.S. lens market remains strong and is shifting to 1-Days lenses from weeklies/monthlies, which is a positive for Cooper Companies (COO), O'Brien contends. Lastly, the analyst says the decline in J&J's U.S. diabetes franchise from the Animas exit was faster than expected. This is good for the pump names Insulet (PODD) and Tandem Diabetes (TNDM) and a slight negative for Dexcom (DXCM) as some of those will end up at Medtronic (MDT), O'Brien argues. He continues to believe that both Insulet and Tandem "will gain more than their fair share" of Animas patients.

TODAY'S FREE FLY STORIES

BECN

Beacon Roofing

$36.71

-0.72 (-1.92%)

15:37
09/25/18
09/25
15:37
09/25/18
15:37
Conference/Events
Beacon Roofing management to meet with Jefferies »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

AIR

AAR Corp.

$45.94

0.95 (2.11%)

15:34
09/25/18
09/25
15:34
09/25/18
15:34
Options
AAR Corp. options imply 8.1% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

SVMK

SurveyMonkey

$0.00

(0.00%)

15:33
09/25/18
09/25
15:33
09/25/18
15:33
Syndicate
SurveyMonkey aiming to price IPO above $9-$11 range, CNBC says »

CNBC cites sources on its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

ULTA

Ulta Beauty

$277.26

-3.75 (-1.33%)

15:25
09/25/18
09/25
15:25
09/25/18
15:25
Conference/Events
Cowen retail/luxury analyst to hold an analyst/industry conference call »

Retail/Luxury Analyst…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 25

    Sep

CTAS

Cintas

$212.44

1.26 (0.60%)

15:19
09/25/18
09/25
15:19
09/25/18
15:19
Options
Cintas options imply 5.4% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

15:17
09/25/18
09/25
15:17
09/25/18
15:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

15:16
09/25/18
09/25
15:16
09/25/18
15:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FTNW

FTE Networks

$12.50

1.24 (11.01%)

15:12
09/25/18
09/25
15:12
09/25/18
15:12
Hot Stocks
FTE Networks CEO says on track to meet or exceed 2018 revenue view of $350M »

FTE Networks provided a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BX

Blackstone

$38.93

-0.77 (-1.94%)

, TRI

Thomson Reuters

$45.70

0.25 (0.55%)

15:11
09/25/18
09/25
15:11
09/25/18
15:11
Periodicals
Breaking Periodicals news story on Blackstone, Thomson Reuters »

Blackstone mulling sale…

BX

Blackstone

$38.93

-0.77 (-1.94%)

TRI

Thomson Reuters

$45.70

0.25 (0.55%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 22

    Oct

WH

Wyndham Hotels & Resorts

$55.42

0.27 (0.49%)

15:10
09/25/18
09/25
15:10
09/25/18
15:10
Conference/Events
Wyndham Hotels & Resorts management to meet with Jefferies »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

JCI

Johnson Controls

$35.65

-0.58 (-1.60%)

15:10
09/25/18
09/25
15:10
09/25/18
15:10
Options
Notable call spread in Johnson Controls »

Notable call spread in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

15:10
09/25/18
09/25
15:10
09/25/18
15:10
General news
Treasury Closing Summary: »

Treasury Closing Summary:…

JBL

Jabil

$27.51

-2.57 (-8.54%)

15:08
09/25/18
09/25
15:08
09/25/18
15:08
Recommendations
Jabil analyst commentary  »

Jabil should be bought on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 27

    Sep

  • 01

    Oct

  • 09

    Oct

  • 13

    Nov

CMTL

Comtech

$34.73

0.77 (2.27%)

15:08
09/25/18
09/25
15:08
09/25/18
15:08
Hot Stocks
Comtech awarded over $4M in additional funding from U.S. Army »

Comtech announced that,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

KBH

KB Home

$25.35

-0.18 (-0.71%)

15:04
09/25/18
09/25
15:04
09/25/18
15:04
Options
KB Home options imply 8.7% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

MYGN

Myriad Genetics

$46.92

0.01 (0.02%)

15:00
09/25/18
09/25
15:00
09/25/18
15:00
Conference/Events
Myriad Genetics management to meet with Jefferies »

Meeting to be held in Los…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

  • 06

    Nov

DAL

Delta Air Lines

$57.10

-0.33 (-0.57%)

15:00
09/25/18
09/25
15:00
09/25/18
15:00
Options
Delta draws a notable call spread as shares tick lower »

Delta draws a notable…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Nov

APRN

Blue Apron

$1.71

0.04 (2.40%)

14:57
09/25/18
09/25
14:57
09/25/18
14:57
Hot Stocks
Blue Apron jumps after O'Leary discusses on CNBC »

Shares of Blue Apron are…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AET

Aetna

$200.71

-2.74 (-1.35%)

, CVS

CVS Health

$77.64

-1.1 (-1.40%)

14:54
09/25/18
09/25
14:54
09/25/18
14:54
Hot Stocks
NY DFS expresses concerns about proposed Aetna, CVS Health deal »

In a letter dated…

AET

Aetna

$200.71

-2.74 (-1.35%)

CVS

CVS Health

$77.64

-1.1 (-1.40%)

ESRX

Express Scripts

$93.26

-1.19 (-1.26%)

CI

Cigna

$200.54

-2.61 (-1.28%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 15

    Oct

ABT

Abbott

$72.00

0.57 (0.80%)

14:50
09/25/18
09/25
14:50
09/25/18
14:50
Hot Stocks
Abbott says study shows Portico safely reduced severe aortic stenosis »

Abbott announced one-year…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 17

    Oct

NKE

Nike

$85.02

0.75 (0.89%)

14:49
09/25/18
09/25
14:49
09/25/18
14:49
Options
Nike options imply 8.5% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

EZPW

Ezcorp

$10.58

0.075 (0.71%)

14:45
09/25/18
09/25
14:45
09/25/18
14:45
Conference/Events
Ezcorp management to meet with Jefferies »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 27

    Sep

  • 06

    Nov

CNDT

Conduent

$22.30

0.12 (0.54%)

14:37
09/25/18
09/25
14:37
09/25/18
14:37
Conference/Events
Conduent management to meet with Jefferies »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 27

    Sep

INTC

Intel

$46.14

-0.77 (-1.64%)

, ADI

Analog Devices

$92.82

-2.19 (-2.31%)

14:36
09/25/18
09/25
14:36
09/25/18
14:36
Hot Stocks
Intel slides as analyst says sell with semis seen in cyclical downturn »

Shares of Intel (INTC)…

INTC

Intel

$46.14

-0.77 (-1.64%)

ADI

Analog Devices

$92.82

-2.19 (-2.31%)

MCHP

Microchip

$79.10

-3.19 (-3.88%)

ON

ON Semiconductor

$18.44

-0.665 (-3.48%)

MPWR

Monolithic Power

$129.88

-2.99 (-2.25%)

AMD

AMD

$32.59

-0.03 (-0.09%)

NVDA

Nvidia

$268.05

2.33 (0.88%)

QCOM

Qualcomm

$73.16

-0.43 (-0.58%)

SIMO

Silicon Motion

$54.13

-0.04 (-0.07%)

MXIM

Maxim Integrated

$58.13

-1.61 (-2.70%)

TXN

Texas Instruments

$107.78

-2.03 (-1.85%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 25

    Sep

  • 26

    Sep

  • 27

    Sep

  • 04

    Oct

  • 08

    Oct

  • 22

    Oct

  • 10

    Dec

  • 08

    May

BRC

Brady

$44.20

0.15 (0.34%)

14:35
09/25/18
09/25
14:35
09/25/18
14:35
Hot Stocks
Brady director Elizabeth Bruno sells over $1M in company stock »

Brady director Elizabeth…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.